Skip to main content
SpringerLink
Log in

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To investigate the utilization and overall survival (OS) impact of concurrent chemotherapy in combination with radiation therapy (RT) for elderly glioblastoma (GBM) patients. Elderly patients (age >70) with supratentorial and nonmetastatic GBM who received RT of 20–75 Gy with concurrent single-agent chemotherapy (ChemoRT) or without (RT alone) during 2004–2012 were identified from the National Cancer Data Base (NCDB). The Cochran-Armitage test was used for trend analysis. Hazard ratios (HR) and 95% confidence intervals (CIs) were determined using Cox proportional hazards. Propensity score analysis was performed to reduce selection bias in treatment allocation. A total of 5252 patients were identified (RT alone: n = 1389; ChemoRT: n = 3863). There was increasing utilization of chemotherapy during this period (45–80%, P < .001). A similar trend was also observed for the subset of age >80 (25–68%, P < .001). ChemoRT was associated with significantly better OS than RT alone (HR 0.79, 95% CI 0.70–0.89, P < .001) on multivariate analysis, and similar OS benefit was demonstrated with 1202 pairs of propensity-matched patients (HR 0.79, 95% CI 0.73–0.86, P < .001). For the matched pair, the median OS was 5.8 months with ChemoRT and 5.0 months with RT alone; the 2-year OS rate was 9% with ChemoRT and 4% with RT alone (P < .001). Concurrent chemotherapy has been administered with RT for the majority of elderly GBM patients. Addition of chemotherapy to RT for elderly GBM patients is associated with significantly improve OS in routine clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-oncology 17(Suppl 4):iv1–iv62. doi:10.1093/neuonc/nov189

    Article  PubMed  PubMed Central  Google Scholar 

  2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi:10.1056/NEJMoa043330

    Article  CAS  PubMed  Google Scholar 

  3. Burton E, Ugiliweneza B, Woo S, Skirboll S, Boaky M (2015) A surveillance, epidemiology and end results-medicare data analysis of elderly patients with glioblastoma multiforme: treatment patterns, outcomes and cost. Mol Clin Oncol 3:971–978. doi:10.3892/mco.2015.590

    PubMed  PubMed Central  Google Scholar 

  4. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY, Association of French-Speaking Neuro-Oncologists (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535. doi:10.1056/NEJMoa065901

    Article  CAS  PubMed  Google Scholar 

  5. Malmstrom A, Gronberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R, Nordic Clinical Brain Tumour Study Group (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916–926. doi:10.1016/S1470-2045(12)70265-6

    Article  PubMed  Google Scholar 

  6. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583–1588. doi:10.1200/JCO.2004.06.082

    Article  CAS  PubMed  Google Scholar 

  7. Roa W, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D, Hentati D, Guedes de Castro D, Dyttus-Cebulok K, Drodge S, Ghosh S, Jeremic B, Rosenblatt E, Fidarova E (2015) International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33:4145–4150. doi:10.1200/JCO.2015.62.6606

    Article  PubMed  Google Scholar 

  8. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M, Society NOASGoN-oWGoGC (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715. doi:10.1016/S1470-2045(12)70164-X

    Article  CAS  PubMed  Google Scholar 

  9. Holdhoff M, Chamberlain MC (2013) Controversies in the treatment of elderly patients with newly diagnosed glioblastoma. J Natl Compr Cancer Netw 11:1165–1172

    CAS  Google Scholar 

  10. Zarnett OJ, Sahgal A, Gosio J, Perry J, Berger MS, Chang S, Das S (2015) Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis. JAMA Neurol 72:589–596. doi:10.1001/jamaneurol.2014.3739

    Article  PubMed  Google Scholar 

  11. Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110:551–555. doi:10.1038/bjc.2013.725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Goodwin PJ, Ballman KV, Small EJ, Cannistra SA (2013) Evaluation of treatment benefit. J Clin Oncol 31:1123–1124. doi:10.1200/JCO.2012.47.6952

    Article  PubMed  Google Scholar 

  13. Tsien CI, Brown D, Normolle D, Schipper M, Piert M, Junck L, Heth J, Gomez-Hassan D, Ten Haken RK, Chenevert T, Cao Y, Lawrence T (2012) Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res 18:273–279. doi:10.1158/1078-0432.CCR-11-2073

    Article  CAS  PubMed  Google Scholar 

  14. Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, Baggstrom MQ, Govindan R, Bell JM, Guthrie TJ, Colditz GA, Crabtree TD, Kreisel D, Krupnick AS, Patterson GA, Meyers BF, Puri V (2015) Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol 33:870–876. doi:10.1200/JCO.2014.58.5380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619

    Article  CAS  PubMed  Google Scholar 

  16. McMurry TL, Hu Y, Blackstone EH, Kozower BD (2015) Propensity scores: methods, considerations, and applications in the Journal of Thoracic Cardiovascular Surgery. J Thorac Cardiovasc Surg 150:14–19. doi:10.1016/j.jtcvs.2015.03.057

    Article  PubMed  Google Scholar 

  17. Samson P, Patel A, Robinson CG, Morgensztern D, Chang SH, Colditz GA, Waqar S, Crabtree TD, Krupnick AS, Kreisel D, Patterson GA, Meyers BF, Puri V (2015) The role of surgical resection in stage IIIA non-small cell lung cancer: a decision and cost-effectiveness analysis. Ann Thorac Surg 100:2026–2032. doi:10.1016/j.athoracsur.2015.05.091

    Article  PubMed  PubMed Central  Google Scholar 

  18. Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083–3107. doi:10.1002/sim.3697

    Article  PubMed  PubMed Central  Google Scholar 

  19. Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gutin PH, Iwamoto FM (2012) Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol 109:391–397. doi:10.1007/s11060-012-0906-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Behm T, Horowski A, Schneider S, Bock HC, Mielke D, Rohde V, Stockhammer F (2013) Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients. Clin Neurol Neurosurg 115:2142–2146. doi:10.1016/j.clineuro.2013.08.002

    Article  PubMed  Google Scholar 

  21. Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M (2011) Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611–618. doi:10.1007/s11060-010-0429-9

    Article  PubMed  Google Scholar 

  22. Yin AA, Zhang LH, Cheng JX, Dong Y, Liu BL, Han N, Zhang X (2013) Radiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis. PloS One 8:e74242. doi:10.1371/journal.pone.0074242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Perry JR, Laperriere N, O’Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay MF, Nishikawa R, Cairncross JG, Roa W, Osoba D, Sahgal A, Hirte HW, Wick W, Laigle-Donadey F, Franceschi E, Chinot OL, Winch C, Ding K, Mason WP (2016) A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma. J Clin Oncol 34(suppl; abstr LBA2)

Download references

Acknowledgements

The Authors wish to acknowledge the Commission on Cancer of the American College of Surgeons and the American Cancer Society for making public data available through the National Cancer Data Base (NCDB). The NCDB is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC’s NCDB and the hospitals participating in the CoC NCDB are the source of the de-identified data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Center for Advanced Medicine, Washington University School of Medicine, 4921 Parkview Place, Campus Box #8224, St. Louis, MO, 63110, USA

    Jiayi Huang, Stephanie M. Perkins, Todd A. DeWees, Christina I. Tsien & Clifford G. Robinson

  2. Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA

    Pamela Samson

  3. Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA

    George Ansstas, Milan G. Chheda & Jian L. Campian

Authors
  1. Jiayi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela Samson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie M. Perkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George Ansstas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Milan G. Chheda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Todd A. DeWees
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christina I. Tsien
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Clifford G. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jian L. Campian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jiayi Huang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 100 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, J., Samson, P., Perkins, S.M. et al. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. J Neurooncol 131, 593–601 (2017). https://doi.org/10.1007/s11060-016-2331-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2331-6

Keywords

Search

Navigation